Palladium-catalyzed azide and amine substitutions enhance antitumor activity in oxindoles, indicating medicinal chemistry potential.
A palladium-catalyzed N-nucleophilic ring-opening reaction of spiro-vinylcyclopropyl oxindoles introducing an azido or a substituted amino group into the C3 position has been developed. Using palladium (0) as the catalyst, the racemic spiro-vinylcyclopropyl oxindoles can not only be converted to their chiral diastereoisomers via a stereoisomerization process but also generate a series of azido-substituted oxindole derivatives through the nucleophilic azide addition or be transformed to tertiary amine-substituted oxindoles through a simple ring-opening process. Notably, the azide products can serve as an important synthetic intermediate to successfully convert to other 3-substituted oxindole derivatives and the spiro[furan-3,3'-oxindoles], which exhibit good antitumor activity in vitro, thus demonstrating their potential applications in medicinal chemistry.
No takes yet. Share an insight, caveat, or question.
Lan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: